What is Lung Cancer Screening Software Market?
Lung cancer screening is a process used for the detection of the presence of lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening software is designed to automate the workflow of healthcare facilities by tracking patients from screening follow-up and beyond, track incidental pulmonary nodules and others.
The market study is being classified and major geographies with country level break-up.
PenRad Technologies, Inc. (United States), Koninklijke Philips N.V. (Netherlands), Kheiron Medical Technologies (United Kingdom), Volpara Solutions Limited (New Zeland), Thynk Health (United States), CRA Health LLC (United States), ProVation Medical, Inc. (United States), Nuance Communications, Inc. (United States), Siemens Healthcare GmbH (Germany) and CureMetrix, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are MobileODT (Israel) and Vital Images, Inc (United States).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Lung Cancer Screening Software market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Lung Cancer Screening Software market by Type, Application and Region.
On the basis of geography, the market of Lung Cancer Screening Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Increased Prevalence of Lung Cancer
- Increased Diagnostic Centres and Hospitals
- Government Initiatives for Cancer Screening Programs
Market Trend
- Growing Awareness about Cancer Screening among People
- Increased Adoption of Cloud-Based Solutions
Restraints
- Technological Complexities associated with Software
- Lack of Skilled Professionals in Some Regions
Opportunities
- Growing Healthcare Industry Worldwide
- New Advancements in the Medical Science
Challenges
- Privacy and Security Issues Associated with Patient Data
- Lack of Funding
Key Target Audience
Lung Cancer Screening Software Developers, Emerging Companies, Research Professionals and End-users